Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,014
Views
7
CrossRef citations to date
0
Altmetric
Laboratory Study

ATRA attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin

Lei ZhangDepartment of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, China; ;Department of Pediatric, Affiliated Hospital of Hebei University, Baoding, ChinaView further author information
,
Xiu-Ping ChenDepartment of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, China; View further author information
,
He QinDepartment of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, China; View further author information
,
Ling JiangDepartment of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, China; View further author information
&
Yuan-Han QinDepartment of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, China; Correspondence[email protected]
View further author information
Pages 266-272 | Received 30 May 2017, Accepted 15 Mar 2018, Published online: 05 Apr 2018

References

  • Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013;76:516–523.
  • Suh JH, Miner JH. The glomerular basement membrane as a barrier to albumin. Nature reviews Nephrology. 2013;9:470–477.
  • Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nature reviews Nephrology. 2013;9:328–336.
  • Grahammer F, Schell C, Huber TB. Molecular understanding of the slit diaphragm. Pediatr Nephrol. 2013;28:1957–1962.
  • Reiser J, Polu KR, Moller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005;37:739–744.
  • Tomilin V, Mamenko M, Zaika O, et al. Role of renal TRP channels in physiology and pathology. Semin Immunopathol. 2016;38:371–383.
  • Zhou TB, Qin YH, Lei FY, et al. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Exp Mol Pathol. 2011;90:287–294.
  • Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137–143.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
  • Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nature reviews Nephrology. 2015;11:76–87.
  • Palm F, Nordquist L. Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1229–R1241.
  • Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol. 2012;23:1917–1928.
  • Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology. 2011;16:30–38.
  • Dietrich A, Gudermann T. TRPC6: physiological function and pathophysiological relevance. Handb Exp Pharmacol. 2014;222:157–188.
  • Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308:1801–1804.
  • Heeringa SF, Moller CC, Du J, et al. A novel TRPC6 mutation that causes childhood FSGS. PLoS One. 2009;4:e7771.
  • Moller CC, Wei C, Altintas MM, et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007;18:29–36.
  • Krall P, Canales CP, Kairath P, et al. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One. 2010;5:e12859.
  • Dryer SE, Reiser J. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol. 2010;299:F689–F701.
  • Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem. 2007;76:387–417.
  • Ilatovskaya DV, Staruschenko A. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Renal Physiol. 2015;309:F393–F397.
  • Sonneveld R, Ferre S, Hoenderop JG, et al. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease. Am J Pathol. 2013;182:1196–1204.
  • Ryningen A, Stapnes C, Paulsen K, et al. In vivo biological effects of ATRA in the treatment of AML. Expert Opin Invest Drugs. 2008;17:1623–1633.
  • Kuendgen A, Strupp C, Aivado M, et al. Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood. 2004;104:1266–1269.
  • Venditti A, Tamburini A, Buccisano F, et al. A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes. Ann Hematol. 2000;79:138–142.
  • Czarnewski P, Das S, Parigi SM, et al. Retinoic acid and its role in modulating intestinal innate immunity. Nutrients. 2017;9:68.
  • Schaier M, Liebler S, Schade K, et al. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med (Berlin, Germany). 2004;82:116–125.
  • Moreno-Manzano V, Mampaso F, Sepulveda-Munoz JC, et al. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol. 2003;139:823–831.
  • Seo K, Rainer PP, Shalkey Hahn V, et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc Natl Acad Sci USA. 2014;111:1551–1556.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.